Knight Therapeutics Inc.

Knight Therapeutics Inc.verified

KHTRF

Price:

$3.8

Market Cap:

$535.51M

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib to treat metastatic cholangiocarcinoma; Trelstar for advanced prostate cancer and for pain associated with endometriosis; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic adenocarcinoma; Halaven for metastatic breast cancer and doft tissue sarcoma; and Lenvima for ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2014-04-03

Stock Exchange

PNK

Ticker

KHTRF

The Current Ratio as of November 2024 (TTM) for Knight Therapeutics Inc. (KHTRF) is 3.36

According to Knight Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.36. This represents a change of 1.13% compared to the average of 3.33 of the last 4 quarters.

Knight Therapeutics Inc. (KHTRF) Historical Current Ratio (quarterly & annually)

How has KHTRF Current Ratio performed in the past?

The mean historical Current Ratio of Knight Therapeutics Inc. over the last ten years is 32.59. The current 3.36 Current Ratio has changed 932.63% with respect to the historical average. Over the past ten years (40 quarters), KHTRF's Current Ratio was at its highest in in the September 2015 quarter at 193.54. The Current Ratio was at its lowest in in the December 2019 quarter at 1.99.

Quarterly (TTM)
Annual

Average

32.59

Median

23.31

Minimum

1.99

Maximum

81.96

Knight Therapeutics Inc. (KHTRF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Knight Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Current Ratio = 81.96

Minimum Annual Increase = -95.23%

Minimum Annual Current Ratio = 1.99

Quarterly (TTM)
Annual
YearCurrent RatioChange
20233.2014.38%
20222.80-4.08%
20212.92-39.98%
20204.86144.31%
20191.99-95.23%
201841.75-25.49%
201756.04-31.63%
201681.9610.60%
201574.1131.80%
201456.23Infinity%

Knight Therapeutics Inc. (KHTRF) Average Current Ratio

How has KHTRF Current Ratio performed in the past?

The current Current Ratio of Knight Therapeutics Inc. (KHTRF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

2.97

5-year avg

3.15

10-year avg

32.59

Knight Therapeutics Inc. (KHTRF) Current Ratio vs. Peers

How is KHTRF’s Current Ratio compared to its peers?

Knight Therapeutics Inc.’s Current Ratio is greater than Crescita Therapeutics Inc. (2.70), greater than Cipher Pharmaceuticals Inc. (2.00), greater than Cannara Biotech Inc. (2.32), greater than Lowell Farms Inc. (0.75), greater than Aion Therapeutic Inc. (0.12), greater than HLS Therapeutics Inc. (1.56), greater than Canntab Therapeutics Limited (0.57), greater than Bionoid Pharma Inc. (0.34), greater than CENTR Brands Corp. (0.10), less than RAMM Pharma Corp. (0), greater than Craftport Cannabis Corp. (0.03), greater than Speakeasy Cannabis Club Ltd. (1.40), greater than City View Green Holdings Inc. (0.01), greater than RavenQuest BioMed Inc. (1.14),

Build a custom stock screener for Knight Therapeutics Inc. (KHTRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Knight Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Knight Therapeutics Inc. (KHTRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Knight Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Knight Therapeutics Inc.'s Current Ratio?

How is the Current Ratio calculated for Knight Therapeutics Inc. (KHTRF)?

What is the highest Current Ratio for Knight Therapeutics Inc. (KHTRF)?

What is the 3-year average Current Ratio for Knight Therapeutics Inc. (KHTRF)?

What is the 5-year average Current Ratio for Knight Therapeutics Inc. (KHTRF)?

How does the current Current Ratio for Knight Therapeutics Inc. (KHTRF) compare to its historical average?